Rarecells rarecells.com


Rarecells was formed to commercialize the ISET (Isolation by Size of Epithelial/Throphoblastic Tumor cells) device to isolate Circulating Rare Cells in blood. ISET forms the base platform for clinical applications in cancer, pre-natal diagnosis and other emerging fields. It is poised to help in detection of CTCs because it addresses the key problems of reliable tumor cell detection: sensitivity and specificity. In addition, an ISET-like system has been developed for the isolation of Circulating ...Show all

Rarecells was formed to commercialize the ISET (Isolation by Size of Epithelial/Throphoblastic Tumor cells) device to isolate Circulating Rare Cells in blood. ISET forms the base platform for clinical applications in cancer, pre-natal diagnosis and o...Show all

Company (Alive / Active)

Phone:

Fax:

156 Rue de Vaugirard
75730
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Rarecells $1.2M Oct 17, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Rarecells Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Process for multi-analyses of rare cells extracted or isolated from biological samples through filtration May 23, 2013 Application